Literature DB >> 9141928

Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.

M R Weglinski1, D J Wedel, A G Engel.   

Abstract

We describe 49 neurologically asymptomatic patients with persistently increased serum creatine kinase (CK) levels (idiopathic hyperCKemia or IHCK) who were referred to our institution for diagnostic muscle biopsy, including malignant hyperthermia (MH) susceptibility testing between 1979 and 1993. Muscle biopsy samples of the vastus lateralis were obtained for histologic analysis and MH contracture testing with halothane and caffeine. From 1979 to November 1987, patients were tested for MH in accordance with a standardized institutional protocol. After November 1987, contracture testing was performed according to the recently adopted North American MH Group protocol. In both protocols, a patient was considered to be MH susceptible (MHS) if one or more muscle strip demonstrated an abnormal contracture response after exposure to 3% halothane, 2% halothane, or caffeine alone. Twenty-four of the 49 IHCK patients (49%) had positive contracture tests. No significant correlation was found between the magnitude of CK increase and the incidence of MHS or histologic abnormalities. Unexplained persistently increased CK levels in an otherwise healthy patient should alert the anesthesiologist to the possibility of MHS and/or myopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141928     DOI: 10.1097/00000539-199705000-00016

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  13 in total

1.  Case report: hyperCKemia: a diagnostic dilemma.

Authors:  Douglas Klein
Journal:  Can Fam Physician       Date:  2005-02       Impact factor: 3.275

2.  Monitoring of serum enzymes in sport.

Authors:  P Brancaccio; F M Limongelli; N Maffulli
Journal:  Br J Sports Med       Date:  2006-02       Impact factor: 13.800

3.  [Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].

Authors:  B Petersen; T Busch; C-D Meinecke; B Börge; K Kluba; U X Kaisers; H Rüffert
Journal:  Anaesthesist       Date:  2015-10-19       Impact factor: 1.041

4.  JSA guideline for the management of malignant hyperthermia crisis 2016.

Authors: 
Journal:  J Anesth       Date:  2017-02-28       Impact factor: 2.078

5.  Asymptomatic hyperCKemia during a two-year monitoring period: A case report and literature overview.

Authors:  Spyridon Klinis; Athanasios Symeonidis; Dimitrios Karanasios; Emmanouil K Symvoulakis
Journal:  Biomed Rep       Date:  2016-11-30

6.  Postoperative hyperthermia of unknown origin treated with dantrolene sodium.

Authors:  Hirohito Inada; Shigeharu Jinno; Hikaru Kohase; Haruhisa Fukayama; Masahiro Umino
Journal:  Anesth Prog       Date:  2005

7.  Postoperative Malignant Hyperthermia- A Medical Emergency: A Case Report and Review of Literature.

Authors:  Amit Kumar Sinha; Poonam Kumari; Maheshkumar Manilal Vaghela; Chandni Sinha; Bindey Kumar
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 8.  Approach to asymptomatic creatine kinase elevation.

Authors:  Siamak Moghadam-Kia; Chester V Oddis; Rohit Aggarwal
Journal:  Cleve Clin J Med       Date:  2016-01       Impact factor: 2.321

9.  Malignant hyperthermia.

Authors:  Dong-Chan Kim
Journal:  Korean J Anesthesiol       Date:  2012-11-16

Review 10.  Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations.

Authors:  Antonella Carsana
Journal:  ScientificWorldJournal       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.